Sindhi Rakesh, Magill Amy, Bentlejewski Carol, Abdullah Ali, Tresgaskes Mary, Seward Joseph, Janosky Janine, Zeevi Adriana
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Am J Transplant. 2005 Jan;5(1):96-102. doi: 10.1111/j.1600-6143.2004.00639.x.
To determine whether early acute cellular rejection (ACR) is associated with sub-optimal immunosuppression in children with liver transplants (LTx).
Twenty-five children with primary LTx after pre-transplant rabbit anti-thymocyte globulin (rATG), and steroid-free tacrolimus (TAC) were evaluated. Mitogen-stimulated T- and B-cell responses and mixed lymphocyte response to donor and third-party antigens were performed at several time points between two consecutive TAC doses. TAC concentrations (C) associated with half-maximal effect (EC(50)) on lymphocytes was determined by pharmacodynamic equations.
Mean age was 7.2 +/- 6.2 years, mean time to lymphocyte function studies was 25 +/- 19 days. Acute rejection occurred at a mean interval of 31 +/- 19 days after LTx. Rejectors (n = 16) demonstrated significantly higher EC(50) of TAC for the intra-cellular IFN-gamma in T cells (p = 0.005) and its CD8+ sub-population (p = 0.027) as well as the co-stimulatory/activation receptor CD54 on B cells (p = 0.0001). The response of recipient lymphocytes to donor antigen was significantly higher in rejectors, compared with non-rejectors (p = 0.015). The patient groups demonstrated no differences in third-party MLR, or in C of TAC.
Independent of the amount of immunosuppressant, ACR of liver allografts in children is associated with enhanced donor-specific alloreactivity. This is accompanied by a cytotoxic T-cell sub-population with increased requirement for TAC.
确定肝移植(LTx)儿童早期急性细胞排斥反应(ACR)是否与免疫抑制不足相关。
对25例移植前接受兔抗胸腺细胞球蛋白(rATG)和无类固醇他克莫司(TAC)治疗的原发性LTx儿童进行评估。在连续两次TAC给药之间的几个时间点进行丝裂原刺激的T细胞和B细胞反应以及对供体和第三方抗原的混合淋巴细胞反应。通过药效学方程确定与淋巴细胞半数最大效应(EC(50))相关的TAC浓度(C)。
平均年龄为7.2±6.2岁,淋巴细胞功能研究的平均时间为25±19天。LTx后急性排斥反应的平均间隔时间为31±19天。发生排斥反应的患者(n = 16)显示TAC对T细胞内干扰素-γ(p = 0.005)及其CD8 +亚群(p = 0.027)以及B细胞上共刺激/激活受体CD54的EC(50)显著更高(p = 0.0001)。与未发生排斥反应的患者相比,发生排斥反应的患者中受体淋巴细胞对供体抗原的反应显著更高(p = 0.015)。两组患者在第三方混合淋巴细胞反应或TAC浓度方面无差异。
儿童肝移植的ACR与供体特异性同种异体反应性增强相关,与免疫抑制剂的用量无关。这伴随着对TAC需求增加的细胞毒性T细胞亚群。